Expression of Multidrug Resistance‐related Transporters in Human Breast Carcinoma

DOI Web Site Web Site 被引用文献2件

抄録

<jats:p>The expression levels of mRNA for multidrug resistance 1 (<jats:italic>MDR1</jats:italic>) gene, multidrug resistance protein 1 (MRP1), lung resistance‐related protein (LRP) and breast cancer resistance protein (BCRP), which confer multidrug resistance <jats:italic>in vitro</jats:italic>, were examined in 43 untreated breast carcinoma patients, of whom 38 subsequently received doxorubicin‐based chemotherapy after surgery, in order to elucidate the roles of these genes in drug resistance <jats:italic>in vivo.</jats:italic> The mRNA levels were determined using a semi‐quantitative reverse‐transcription polymerase chain reaction method in breast carcinoma tissues including at least 80% carcinoma cells. The expression level of <jats:italic>BCRP</jats:italic> gene was low and did not vary markedly in comparison with that of <jats:italic>MDR1, MRP1</jats:italic> or <jats:italic>LRP</jats:italic> gene. The expressions of <jats:italic>MDR1</jats:italic> and <jats:italic>MRP1</jats:italic> genes were correlated with each other, but the expression of <jats:italic>BCRP</jats:italic> or <jats:italic>LRP</jats:italic> gene did not correlate with that of other genes. These four gene expressions were independent of age, TNM categories and the status of progesterone or estrogen receptor. The expression levels of these four genes were not related to the relapse or prognosis of the 38 patients treated with doxorubicin‐based chemotherapy. P‐glycoprotein (P‐gp)/MDRl, MRP1 and LRP may play more important roles than BCRP in chemotherapy of human breast carcinoma.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ